Insiders · Profile

Capone Mark Christopher

Director at MESA LABORATORIES INC /CO/ · President & C.E.O. at MYRIAD GENETICS. Filing since 7 Aug 2007. CIK 0001352413

Company
Date
Role
Action
Shares
Amount
Of holding
10 Mar 2026
Director
Bought
1,301
$99.33K
61.1%
1 Aug 2019
President & C.E.O.
Sold, plan not stated
137,000
$6.03M
23.7%
11 Jul 2018
President & C.E.O.
Sold, plan not stated
80,000
$3.28M
19.4%
30 May 2018
President & C.E.O.
Sold, plan not stated
90,000
$3.42M
21.3%
19 Aug 2016
President & C.E.O.
Bought
10,000
$212.40K
7.4%
25 Feb 2014
President, MGL
Sold, plan not stated
95,250
$3.60M
66.4%
10 Feb 2014
President, MGL
Sold, plan not stated
87,500
$2.81M
64.4%
16 May 2013
President, MGL
Sold, plan not stated
79,999
$2.66M
62.4%
21 Nov 2012
President, MGL
Sold, plan not stated
314
$9.43K
0.6%
20 Nov 2012
President, MGL
Sold, plan not stated
35,010
$1.06M
42.0%
12 Nov 2012
President, MGL
Sold, plan not stated
62,176
$1.86M
56.3%
6 Nov 2012
President, MGL
Sold, plan not stated
27,000
$776.25K
35.9%
10 Sep 2012
President, MGL
Sold, plan not stated
19,805
$534.74K
28.7%
2 May 2012
President, MGL
Sold, plan not stated
4,257
$114.94K
8.0%
6 Apr 2009
Chief Operating Officer, MGL
Sold, plan not stated
36,000
$1.55M
63.8%
9 Feb 2009
Chief Operating Officer, MGL
Sold, plan not stated
21,893
$1.87M
87.9%
29 Aug 2008
Chief Operating Officer, MGL
Sold, plan not stated
18,000
$1.22M
74.7%
7 Aug 2007
Chief Operating Officer, MGL
Sold, plan not stated
4,773
$205.27K
44.0%
18 decisions on file.